Alfredo Zurlo, a veteran oncologist, has joined Berlin-based Glycotope GmbH as chief medical officer. Dr Zurlo was previously CMO and executive board member at Mologen AG and before that, a senior scientist at the Roche Group. He has also been medical advisor for the European Organisation for the Research and Treatment of Cancer. Dr Zurlo completed his oncology and radio-oncology training at the University of Rome.
Glycotope announced the appointment on 29 April 2016.
Copyright 2016 Evernow Publishing Ltd